Home
Data
Calendar
Blog
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Value | 0.20 | 0.20 | 0.19 | 0.19 | 0.17 | 0.16 | 0.16 | 0.16 | 0.15 | NA | NA | 0.13 | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | 1950.81 | 1933.44 | 1.92 | NA | 1630.91 | 1620.70 | 1.61 | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Shares Outstanding Basic | 1950.81 | 1933.44 | 1.91 | NA | 1630.91 | 1620.70 | 1.61 | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Basic | -0.16 | -0.09 | -0.11 | -0.06 | -0.41 | -0.41 | -0.37 | -1.17 | -0.08 | -0.04 | NA | NA | NA | |
| Earnings Per Share Diluted | -0.16 | -0.09 | -0.11 | -0.06 | -0.41 | -0.41 | -0.37 | -1.21 | -0.08 | -0.04 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 55.43 | 80.57 | 80.70 | 98.28 | 66.40 | 144.62 | 168.41 | 148.49 | 77.61 | 43.64 | 44.10 | 32.06 | 13.30 | |
| Gain Loss On Investments | -36.32 | -2.12 | -6.37 | -13.35 | -1.76 | -38.67 | 0.45 | -14.55 | -12.37 | 2.75 | 12.62 | 1.25 | -0.09 | |
| Operating Expenses | 341.82 | 264.72 | 296.45 | 332.79 | 719.42 | 791.53 | 842.92 | 1833.23 | 104.28 | 103.58 | 101.21 | 87.95 | 47.72 | |
| Research And Development Expense | 156.66 | 144.28 | 162.64 | 181.16 | 259.58 | 289.19 | 322.72 | 985.02 | 53.02 | 52.03 | 59.59 | 61.19 | 36.07 | |
| General And Administrative Expense | 82.03 | 102.34 | 111.43 | 121.42 | 435.18 | 438.43 | 434.77 | 781.63 | 28.96 | 5.31 | 17.93 | 12.91 | 9.88 | |
| Operating Income Loss | -286.39 | -184.15 | -215.75 | -234.51 | -653.02 | -646.91 | -674.51 | -1684.73 | -26.67 | -5.31 | -57.12 | -55.89 | -34.41 | |
| Interest Income Expense Net | 15.02 | 14.35 | 14.54 | NA | 5.82 | 1.67 | -0.40 | -98.37 | 75.94 | -0.48 | -0.47 | 14.89 | -8.29 | |
| Allocated Share Based Compensation Expense | 52.57 | 61.49 | 72.99 | 108.17 | 563.14 | 606.51 | 652.82 | 1667.80 | 0.13 | 14.52 | 0.12 | 0.12 | 0.12 | |
| Income Tax Expense Benefit | -0.02 | 0.07 | 0.08 | -14.77 | -0.03 | -0.04 | -0.18 | -0.68 | -0.21 | -0.43 | -0.16 | 0.01 | 0.01 | |
| Income Taxes Paid Net | NA | NA | NA | 0.00 | 0.00 | 0.00 | 0.98 | NA | NA | NA | NA | NA | NA | |
| Profit Loss | -302.89 | -173.31 | -204.97 | -174.15 | -669.05 | -670.57 | -592.59 | -1604.99 | -102.41 | -54.46 | -74.78 | -46.40 | -26.13 | |
| Other Comprehensive Income Loss Net Of Tax | -1.60 | NA | NA | NA | -2.41 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Net Income Loss | -302.89 | -173.31 | -204.97 | -176.54 | -669.05 | -668.83 | -590.50 | -1600.66 | -101.88 | -106.76 | 5.76 | -46.92 | -26.05 | |
| Comprehensive Income Net Of Tax | -304.49 | -173.00 | -203.95 | -168.88 | -671.47 | -673.71 | -593.23 | -1605.83 | -103.28 | -54.46 | -74.78 | -46.40 | -26.13 |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 2026.39 | 2292.00 | 2417.21 | 2539.32 | 1870.69 | 1994.22 | 2057.73 | 2070.99 | 2150.59 | 1725.99 | 1728.03 | 1.25 | NA | |
| Liabilities | 773.71 | 788.41 | 809.62 | 803.04 | 430.96 | 427.16 | 443.68 | 503.61 | 532.62 | 254.95 | 150.14 | 1.23 | NA | |
| Liabilities And Stockholders Equity | 2026.39 | 2292.00 | 2417.21 | 2539.32 | 1870.69 | 1994.22 | 2057.73 | 2070.99 | 2150.59 | 1725.99 | 1728.03 | 1.25 | NA | |
| Stockholders Equity | NA | NA | NA | 1736.28 | 1434.74 | 1535.43 | 1580.80 | 1505.37 | 1551.55 | 5.00 | 5.00 | 0.02 | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 1141.85 | 1223.45 | 1327.31 | 1450.08 | 1462.00 | 1598.85 | 1705.83 | 1723.05 | 1810.57 | 0.97 | NA | 426.54 | NA | |
| Cash And Cash Equivalents At Carrying Value | 1049.24 | 1105.79 | 1206.09 | 1315.79 | 1302.60 | 1377.15 | 1492.97 | 1550.00 | 1739.06 | 0.04 | 1.92 | 0.00 | 471.06 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1094.62 | 1172.06 | 1258.67 | 1369.58 | 1345.51 | 1420.84 | 1535.85 | 1592.93 | 1765.30 | 253.30 | 314.27 | 385.88 | 474.23 | |
| Accounts Receivable Net Current | 61.90 | 68.02 | 83.26 | 80.91 | 113.66 | 171.62 | 167.26 | 131.54 | 44.67 | NA | NA | 16.69 | NA | |
| Inventory Net | 0.07 | 0.39 | 2.51 | 4.36 | 5.86 | 8.10 | 8.70 | 3.36 | 3.47 | NA | NA | 2.74 | NA | |
| Inventory Finished Goods | NA | 4.43 | 5.30 | 6.56 | 5.59 | 7.52 | 7.98 | 3.26 | 2.53 | NA | NA | 2.76 | NA | |
| Other Assets Current | NA | NA | NA | 0.49 | NA | NA | NA | 0.70 | NA | NA | NA | 0.68 | NA | |
| Prepaid Expense And Other Assets Current | 29.39 | 48.36 | 33.87 | 47.46 | 37.78 | 38.72 | 33.09 | 33.54 | 17.31 | NA | NA | 21.10 | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Property Plant And Equipment Gross | 322.31 | 412.71 | 421.23 | 407.53 | 271.01 | 254.43 | 218.95 | 206.82 | 196.54 | NA | NA | 155.21 | NA | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 120.71 | 118.47 | 107.26 | 92.76 | 83.43 | 78.21 | 69.78 | 61.05 | 53.84 | NA | NA | 33.78 | NA | |
| Amortization Of Intangible Assets | 4.00 | 4.00 | 4.30 | 3.30 | 1.00 | 0.80 | 0.40 | 0.50 | 0.40 | 0.20 | 0.10 | 0.10 | 0.10 | |
| Property Plant And Equipment Net | 201.59 | 294.24 | 313.97 | 314.77 | 187.58 | 176.22 | 149.17 | 145.77 | 142.70 | NA | NA | 121.44 | NA | |
| Goodwill | 58.06 | 58.83 | 58.73 | 60.21 | 28.80 | 30.97 | 21.04 | 21.31 | 16.66 | NA | NA | 1.86 | NA | |
| Intangible Assets Net Excluding Goodwill | 100.17 | 105.03 | 108.74 | 111.04 | 47.94 | 39.18 | 20.83 | 21.64 | 22.57 | NA | NA | 3.29 | NA | |
| Finite Lived Intangible Assets Net | 100.17 | 105.03 | 108.74 | 111.04 | 47.94 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Other Assets Noncurrent | 97.02 | 97.95 | 97.26 | 88.72 | 43.93 | 53.02 | 49.62 | 43.99 | 26.80 | NA | NA | 5.60 | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 168.46 | 163.33 | 191.70 | 172.96 | 124.82 | 135.02 | 159.25 | 134.76 | 90.31 | 4.69 | 1.42 | 1.23 | NA | |
| Accounts Payable Current | 10.75 | 13.63 | 21.57 | 10.45 | 11.32 | 19.46 | 35.26 | 8.19 | 7.10 | NA | NA | 13.89 | NA | |
| Other Accrued Liabilities Current | NA | NA | NA | 14.00 | NA | NA | NA | 9.06 | NA | NA | NA | 2.27 | NA | |
| Accrued Liabilities Current | NA | NA | NA | 114.69 | NA | NA | NA | 93.33 | NA | NA | NA | 30.50 | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Minority Interest | NA | NA | NA | NA | 5.00 | 31.62 | 33.25 | 62.01 | 66.42 | NA | NA | 8.68 | NA | |
| Other Liabilities Noncurrent | 19.32 | 20.10 | 29.34 | 31.19 | 34.92 | 36.11 | 16.88 | 35.99 | 33.11 | NA | NA | 3.03 | NA | |
| Operating Lease Liability Noncurrent | 403.66 | 410.94 | 404.10 | 413.26 | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | NA | NA | NA | 1736.28 | 1434.74 | 1535.43 | 1580.80 | 1505.37 | 1551.55 | 5.00 | 5.00 | 0.02 | NA | |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1252.68 | 1503.59 | 1607.59 | 1736.28 | 1439.74 | 1567.06 | 1614.05 | 1567.38 | 1617.97 | 355.79 | 395.57 | 470.05 | 516.33 | |
| Common Stock Value | 0.20 | 0.20 | 0.19 | 0.19 | 0.17 | 0.16 | 0.16 | 0.16 | 0.15 | NA | NA | 0.13 | NA | |
| Additional Paid In Capital | 6334.22 | 6280.63 | 6211.63 | 6136.38 | 5668.79 | 5098.02 | 4471.42 | 3804.84 | 2249.55 | 105.99 | NA | 0.02 | NA | |
| Retained Earnings Accumulated Deficit | -5078.83 | -4775.94 | -4602.63 | -4397.66 | -4226.31 | -3557.26 | -2888.43 | -2297.93 | -697.27 | -101.00 | 4.99 | -0.01 | NA | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -2.90 | -1.30 | -1.61 | -2.63 | -7.91 | -5.50 | -2.35 | -1.72 | -0.88 | NA | NA | NA | NA | |
| Minority Interest | NA | NA | NA | NA | 5.00 | 31.62 | 33.25 | 62.01 | 66.42 | NA | NA | 8.68 | NA | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 52.57 | 62.47 | 72.98 | 108.16 | 563.14 | 606.59 | 669.59 | 1564.64 | 0.13 | 14.52 | 0.12 | NA | 0.12 |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -73.55 | -73.53 | -90.58 | -104.70 | -28.30 | -99.30 | -19.90 | -165.54 | -85.50 | 45.36 | -48.13 | -59.34 | NA | |
| Net Cash Provided By Used In Investing Activities | -3.38 | -11.22 | -19.41 | 29.74 | -46.49 | -14.66 | -35.98 | 4.23 | 1647.39 | -1701.83 | -23.05 | -28.83 | NA | |
| Net Cash Provided By Used In Financing Activities | -0.32 | -1.38 | -0.89 | 97.93 | -0.45 | -0.95 | -1.19 | -11.04 | -182.50 | 1728.12 | -0.43 | -0.19 | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -73.55 | -73.53 | -90.58 | -104.70 | -28.30 | -99.30 | -19.90 | -165.54 | -85.50 | 45.36 | -48.13 | -59.34 | NA | |
| Net Income Loss | -302.89 | -173.31 | -204.97 | -176.54 | -669.05 | -668.83 | -590.50 | -1600.66 | -101.88 | -106.76 | 5.76 | -46.92 | -26.05 | |
| Profit Loss | -302.89 | -173.31 | -204.97 | -174.15 | -669.05 | -670.57 | -592.59 | -1604.99 | -102.41 | -54.46 | -74.78 | -46.40 | -26.13 | |
| Increase Decrease In Accounts Receivable | -22.97 | 0.00 | 1.80 | -34.50 | NA | NA | NA | 86.26 | NA | NA | NA | 7.89 | NA | |
| Increase Decrease In Inventories | NA | -0.69 | -1.85 | -2.66 | -2.24 | -0.59 | 5.33 | -0.11 | 0.76 | -0.70 | 0.68 | 1.92 | NA | |
| Increase Decrease In Accounts Payable | NA | -6.69 | 9.68 | -14.74 | -6.76 | -15.60 | 26.25 | 0.52 | 4.55 | -7.84 | 0.52 | 4.32 | NA | |
| Share Based Compensation | 52.57 | 61.49 | 72.99 | 108.17 | 563.14 | 606.51 | 652.82 | 1591.26 | 0.13 | 14.52 | 0.12 | 0.12 | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | -3.38 | -11.22 | -19.41 | 29.74 | -46.49 | -14.66 | -35.98 | 4.23 | 1647.39 | -1701.83 | -23.05 | -28.83 | NA | |
| Payments To Acquire Property Plant And Equipment | 4.38 | 13.53 | 19.44 | 25.64 | 13.47 | 9.57 | 3.58 | 5.11 | 5.44 | 24.03 | 21.93 | 19.41 | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | -0.32 | -1.38 | -0.89 | 97.93 | -0.45 | -0.95 | -1.19 | -11.04 | -182.50 | 1728.12 | -0.43 | -0.19 | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | NA | 6.51 | NA | NA | NA | 7.97 | NA | NA | NA | NA | NA | NA | NA | |
| Related Party, Allonnia | NA | 0.16 | NA | NA | NA | 0.44 | NA | NA | NA | NA | NA | NA | NA | |
| Related Party, Arcaea | NA | 4.23 | NA | NA | NA | 2.36 | NA | NA | NA | NA | NA | NA | NA | |
| Related Party, Ayana | NA | 0.18 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Related Party, Biomedit | NA | 0.87 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Related Party, Genomatica | NA | 0.78 | NA | NA | NA | 2.40 | NA | NA | NA | NA | NA | NA | NA | |
| Related Party, Joyn | NA | NA | NA | NA | NA | 0.95 | NA | NA | NA | NA | NA | NA | NA | |
| Related Party, Motif | NA | 0.00 | NA | NA | NA | 0.51 | NA | NA | NA | NA | NA | NA | NA | |
| Related Party, Verb | NA | 0.08 | NA | NA | NA | 0.64 | NA | NA | NA | NA | NA | NA | NA | |
| Related Party, Equity Method Investment Nonconsolidated Investee Or Group Of Investees | NA | 0.20 | NA | NA | NA | 0.67 | NA | NA | NA | NA | NA | NA | NA | |
| Codm | NA | 80.57 | 80.70 | 98.28 | 66.40 | 144.62 | 168.41 | 148.49 | 77.61 | 43.64 | 44.10 | NA | NA | |
| Codm, Biosecurity | NA | 35.28 | 46.61 | 291.36 | 17.04 | 100.38 | 146.92 | 179.54 | 11.69 | 22.04 | 21.59 | NA | NA | |
| Codm, Cell Engineering Revenue | NA | 45.28 | 34.10 | NA | NA | 44.24 | 21.49 | NA | NA | NA | NA | NA | NA | |
| Codm, Foundry Revenue | NA | NA | NA | 53.26 | 24.68 | 44.24 | 21.49 | 34.16 | 34.74 | 21.59 | 22.50 | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 55.43 | 80.57 | 80.70 | 98.28 | 66.40 | 144.62 | 168.41 | 148.49 | 77.61 | 43.64 | 44.10 | 32.06 | 13.30 | |
| Operating, Biosecurity | 18.25 | NA | NA | NA | 41.72 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Operating, Cell Engineering | 37.18 | NA | NA | NA | 24.68 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Allonnia, Related Party | 0.18 | NA | NA | NA | 0.58 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Arcaea, Related Party | NA | NA | NA | NA | 4.01 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ayana, Related Party | 0.33 | NA | NA | NA | 0.69 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Biomedit, Related Party | 0.63 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Genomatica, Related Party | 1.01 | NA | NA | NA | 2.74 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Joyn, Related Party | NA | NA | NA | NA | 0.69 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Motif, Related Party | 6.30 | NA | NA | NA | 0.08 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Other Equity Investee, Related Party | 0.20 | NA | NA | NA | 0.41 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Verb, Related Party | 0.07 | NA | NA | NA | 0.82 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Cell Engineering Revenue | 37.18 | 45.28 | 34.10 | NA | 24.68 | 44.24 | 21.49 | NA | NA | NA | NA | NA | NA | |
| Foundry Revenue | NA | NA | NA | 53.26 | 24.68 | 44.24 | 21.49 | 34.16 | 34.74 | 21.59 | 22.50 | NA | NA | |
| Safe | NA | 0.00 | 11.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Product | 6.50 | 10.79 | 11.67 | 12.43 | 5.19 | 3.89 | 13.95 | 8.42 | 8.49 | 0.35 | 5.78 | NA | NA | |
| Service | 11.76 | 24.50 | 34.94 | 32.60 | 36.53 | 96.49 | 132.97 | 105.92 | 34.38 | 21.69 | 15.82 | 6.93 | 1.80 | |
| Related Party | 8.73 | NA | NA | NA | 10.03 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Cell Engineering And Biosecurity | 55.43 | NA | NA | NA | 66.40 | NA | NA | NA | NA | NA | NA | NA | NA |
